Trials / Completed
CompletedNCT04600544
Russian Disc Degeneration Study
Disease-oriented Russian Disc Degeneration Study (RuDDS) Biobank Facilitating Functional Omics Studies of Lumbar Disc Degeneration
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,070 (actual)
- Sponsor
- Novosibirsk State University · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- —
Summary
The main aim of this study is to establish disease-oriented biobank to facilitate research in biology of the lumbar disc degeneration. Diverse biological samples (whole blood, plasma, disc tissue) along with MRI imaging, clinical, socio-demographic and various omics data (e.g. genomic and transcriptomic) will be available for researchers and clinicians for a variety of further multi-omics studies. It will lay the groundwork for the development of early diagnostics of DDD and its personalized treatment. The study is planned to enroll up to 1,100 patients with different grades of lumbar disc degeneration. It is planned to recruit patients within 36 months.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Non-interventional | Translational, observational study |
Timeline
- Start date
- 2020-10-16
- Primary completion
- 2022-10-19
- Completion
- 2024-12-10
- First posted
- 2020-10-23
- Last updated
- 2024-12-24
Locations
3 sites across 1 country: Russia
Source: ClinicalTrials.gov record NCT04600544. Inclusion in this directory is not an endorsement.